We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Urgent safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Applications received to amend the specification of a patent under sections 27 and 75 before the court and the Office.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Jan - 31 Mar 2024.
Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.
Find out details of the procedure codes and additional procedure codes that are excluded from use with Simplified Declaration Procedure (SDP) with regular use and Entry in Declarants Records (EIDR).
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Environmental regulations and guidance on offshore oil and gas exploration and production, offshore gas unloading and storage and offshore carbon dioxide storage activities
The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.
The CMA investigated the anticipated acquisition by Theramex HQ UK Limited of the European Rights to Viatris’ Femoston and Duphaston Products.
Guide to submitting employer licence applications to the Administration of Radioactive Substances Advisory Committee (ARSAC).
The management, surveillance and epidemiology of carbapenem resistance.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Details of certificates issued under the Special Import System for the top ten veterinary medicines that were imported 1 Oct - 31 Dec 2023.
RIDA funds research and development in new technologies, and new approaches to existing technologies, that support Sustainable Development Goals in south-east Asia.
The Industrial Heat Recovery Support (IHRS) programme was designed to encourage and support investment in heat recovery technologies.
NCARDRS records those people with congenital abnormalities and rare diseases across the whole of England.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).